Carvolix

Update in progress

CVX.PA (Paris)

Company RatingNeutral
SectorHealthcare
IndustryMedical Devices

Carvolix SA is a medical technology company focused on minimally invasive devices for urology and structural heart conditions in France. Its products include Artus, an implantable electro-mechanical sphincter for moderate to severe urinary incontinence; Kalios and Epygon for mitral insufficiency; and Kardiozis for abdominal aortic aneurysm. Formerly Affluent Medical SA, it rebranded to Carvolix in February 2026. Founded in 2011, based in Aix-en-Provence.

Company score

Sentiment: 0.34; SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
Environment: 0.00; EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
Social: 0.23; SocialAssesses the company’s influence on employees, customers, communities, and wider society.−10 negative · 0 neutral · +10 positive
Governance: 0.13; GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
Sustainability: 0.09; SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
Impact Score: 0.22; Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive